Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Vocadlo

Showing results (11-20 of 172) with videos related to

Pageof 18
Sort By:
Current Alzheimer Research|October 31, 2009
O-GlcNAc modification and the tauopathies: insights from chemical biologyScott A Yuzwa, David J Vocadlo
Current Opinion in Chemical Biology|June 19, 2008
Mechanistic insights into glycosidase chemistryDavid J Vocadlo, Gideon J Davies
Biochimica Et Biophysica Acta|August 12, 2009
Increasing O-GlcNAc levels: An overview of small-molecule inhibitors of O-GlcNAcaseMatthew S Macauley, David J Vocadlo
Carbohydrate Research|May 9, 2009
Enzymatic characterization and inhibition of the nuclear variant of human O-GlcNAcaseMatthew S Macauley, David J Vocadlo
Methods in Molecular Biology (Clifton, N.J.)|December 16, 2016
Production of O-GlcNAc Modified Recombinant Tau in E. coli and Detection of Ser400 O-GlcNAc Tau In VivoScott A Yuzwa, David J Vocadlo
Nature Chemical Biology|July 20, 2012
Developing inhibitors of glycan processing enzymes as tools for enabling glycobiologyTracey M Gloster, David J Vocadlo
The Journal of Biological Chemistry|November 2, 2023
Understanding and exploiting the roles of O-GlcNAc in neurodegenerative diseasesMatthew R Pratt, David J Vocadlo
The FEBS Journal|May 5, 2020
Pharmacological inhibition and knockdown of O-GlcNAcase reduces cellular internalization of α-synuclein preformed fibrilsOmid Tavassoly, Jefferey Yue, David J Vocadlo
Neuroscience Letters|April 24, 2012
Reduced protein O-glycosylation in the nervous system of the mutant SOD1 transgenic mouse model of amyotrophic lateral sclerosisXiaoyang Shan, David J Vocadlo, Charles Krieger
The Journal of Biological Chemistry|April 18, 2013
Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cellsZhiyuan Ma, David J Vocadlo, Keith Vosseller
Pageof 18

Showing results (11-20 of 172) with videos related to

Sort By:
Pageof 18
Current Alzheimer Research|October 31, 2009
O-GlcNAc modification and the tauopathies: insights from chemical biologyScott A Yuzwa, David J Vocadlo
Current Opinion in Chemical Biology|June 19, 2008
Mechanistic insights into glycosidase chemistryDavid J Vocadlo, Gideon J Davies
Biochimica Et Biophysica Acta|August 12, 2009
Increasing O-GlcNAc levels: An overview of small-molecule inhibitors of O-GlcNAcaseMatthew S Macauley, David J Vocadlo
Carbohydrate Research|May 9, 2009
Enzymatic characterization and inhibition of the nuclear variant of human O-GlcNAcaseMatthew S Macauley, David J Vocadlo
Methods in Molecular Biology (Clifton, N.J.)|December 16, 2016
Production of O-GlcNAc Modified Recombinant Tau in E. coli and Detection of Ser400 O-GlcNAc Tau In VivoScott A Yuzwa, David J Vocadlo
Nature Chemical Biology|July 20, 2012
Developing inhibitors of glycan processing enzymes as tools for enabling glycobiologyTracey M Gloster, David J Vocadlo
The Journal of Biological Chemistry|November 2, 2023
Understanding and exploiting the roles of O-GlcNAc in neurodegenerative diseasesMatthew R Pratt, David J Vocadlo
The FEBS Journal|May 5, 2020
Pharmacological inhibition and knockdown of O-GlcNAcase reduces cellular internalization of α-synuclein preformed fibrilsOmid Tavassoly, Jefferey Yue, David J Vocadlo
Neuroscience Letters|April 24, 2012
Reduced protein O-glycosylation in the nervous system of the mutant SOD1 transgenic mouse model of amyotrophic lateral sclerosisXiaoyang Shan, David J Vocadlo, Charles Krieger
The Journal of Biological Chemistry|April 18, 2013
Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cellsZhiyuan Ma, David J Vocadlo, Keith Vosseller
Pageof 18